From at-a-glance updates on important HTA decisions, to reviews that shine a spotlight on what those decisions mean for specific therapeutic areas, each edition of the HTA Quarterly provides insight into the evolving perspectives and priorities for HTAs; as well as Xcenda’s unique perspective so you are more prepared to address the challenges of an uncertain and rapidly changing healthcare environment.

Health Policy Weekly recaps legislative and regulatory developments and healthcare reform news that impacts the healthcare industry, particularly pharmaceutical, biotech, and device manufacturers, providers, and managed care. Developed by a multidisciplinary editorial board that includes Xcenda’s health policy and reimbursement strategy specialists, Health Policy Weekly is delivered to your inbox every Friday.